Tag: research

The Complex Genetic Architecture Underlying Human Differences

You’d be forgiven for assuming your height has nothing to do with the curl of your hair or how flexible you are, but physical traits can sometimes have unexpected connections. Last week at the annual meeting of the American Society of Human Genetics in San Francisco, 23andMe’s Principal Scientist and ...

Read more

23andMe Presents Latest Research at ASHG

(Editor's note: Here's a link to a post with the links to all the poster presentations given by 23andMe scientists at 23andMe.) Here we come. Starting today a contingent of 23andMe’s scientists and researchers will be at the American Society of Human Genetics Annual Meeting in San Francisco. ...

Read more

23 A Go-Go

(Editor's note: We've heard from some of you about issues with the new app. We're addressing many of those now. For updates and more information go here. Thanks.) Because we know your genes are made for walking, we’ve added a new 23andMe mobile app. Available as a download on Apple’s iTunes App Store ...

Read more

Novel Genetic Findings for Myeloproliferative Neoplasms

Dave Hinds is a Principal Scientist in Statistical Genetics.  23andMe is passionate about research on a group of rare blood disorders called myeloproliferative neoplasms, or MPNs. Physicians who study these disorders consider them to be blood cancers, though individual prognoses can vary widely — some people ...

Read more

The Genetics of Nearsightedness, Stretch Marks, and Motion Sickness

Amy Kiefer is a Survey Research Manager at 23andMe. She joined the company in 2008. What do nearsightedness, stretch marks, and motion sickness have to do with each other? They don’t appear to be genetically related — at least not according to our in-house statistical geneticists — but all of them are ...

Read more

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research ...

Read more

Fighting Rare Blood Cancers

Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of enrolling 1,000 patients and are encouraged by what we’ve already learned. We’re also humbled that another star in the ...

Read more

Participating in Genetic Research

Not all cancers are created equal. Ask anyone with metastatic breast cancer. For the 155,000 women in the United States living with this diagnosis, each day represents a constant fight against a cancer that has spread into other parts of their bodies — most often their bones, liver, lungs or brain. With ...

Read more

A Milestone in Sarcoma Research

Each person who has joined 23andMe’s Sarcoma research community has their own reasons for participating, but they all share the same hopes that we have — to find the causes for sarcoma and new treatments for this rare cancer. Earlier this month, 23andMe took an important step in that direction when we ...

Read more

Leveraging The Direct-to-Patient Research Model in Rheumatoid Arthritis

Janssen Healthcare Innovation, a unit of Janssen Research & Development, LLC, is sponsoring a study in rheumatoid arthritis patients that will be conducted by MediGuard.org (a subsidiary of Quintiles) and 23andMe. The study, called TogetherRA, will enroll approximately 1,000 patients who are currently ...

Read more

Return to top